Ketoconazole inhibits multiple steroidogenic enzymes involved in androgen biosynthesis in the human ovary

M. DiMattina, N. Maronian, H. Ashby, Donald (Lynn) Loriaux, B. D. Albertson

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Ketoconazole (KZ) has been shown to inhibit testicular and adrenal steroidogenesis and is useful in the medical management of gonadotropin-independent precocious puberty, prostatic cancer, and Cushing's syndrome. To determine whether KZ similarly affects ovarian steroidogenesis, the authors examined its effect on the activity of the human ovarian 3β-hydroxysteroid dehydrogenase/isomerase (3β-HSD), 17-hydroxylase (17-OH), and aromatase (AR) in vitro. A dose-dependent decrease in the activities of 3β-HSD and 17-OH was observed with increasing amounts of KZ. With 10, 50, and 100-fold excess KZ, the activity of 3β-HSD decreased by 59% (P <0.001), 73% (P <0.005), and 85% (P <0.005), respectively. At equimolar concentrations with substrate (50 μM), KZ inhibited 17-OH by 70% (P <0.01). No significant effect on ovarian AR activity was observed, except at the highest concentration of KZ tested. The authors conclude that low concentrations of KZ profoundly inhibit the activity of human ovarian 3β-HSD and 17-OH in vitro. These observations suggest that KZ might be useful in the medical management of women with hyperandrogenism, but further experimentation and clinical trials will be necessary.

Original languageEnglish (US)
Pages (from-to)62-65
Number of pages4
JournalFertility and Sterility
Volume49
Issue number1
StatePublished - 1988
Externally publishedYes

Fingerprint

Ketoconazole
Androgens
Ovary
3-Hydroxysteroid Dehydrogenases
Isomerases
Enzymes
Aromatase
Human Activities
Hyperandrogenism
Cushing Syndrome
Mixed Function Oxygenases
Prostatic Neoplasms
Clinical Trials

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Ketoconazole inhibits multiple steroidogenic enzymes involved in androgen biosynthesis in the human ovary. / DiMattina, M.; Maronian, N.; Ashby, H.; Loriaux, Donald (Lynn); Albertson, B. D.

In: Fertility and Sterility, Vol. 49, No. 1, 1988, p. 62-65.

Research output: Contribution to journalArticle

DiMattina, M. ; Maronian, N. ; Ashby, H. ; Loriaux, Donald (Lynn) ; Albertson, B. D. / Ketoconazole inhibits multiple steroidogenic enzymes involved in androgen biosynthesis in the human ovary. In: Fertility and Sterility. 1988 ; Vol. 49, No. 1. pp. 62-65.
@article{3c5f0d0f5ca342ea97b9b516246816eb,
title = "Ketoconazole inhibits multiple steroidogenic enzymes involved in androgen biosynthesis in the human ovary",
abstract = "Ketoconazole (KZ) has been shown to inhibit testicular and adrenal steroidogenesis and is useful in the medical management of gonadotropin-independent precocious puberty, prostatic cancer, and Cushing's syndrome. To determine whether KZ similarly affects ovarian steroidogenesis, the authors examined its effect on the activity of the human ovarian 3β-hydroxysteroid dehydrogenase/isomerase (3β-HSD), 17-hydroxylase (17-OH), and aromatase (AR) in vitro. A dose-dependent decrease in the activities of 3β-HSD and 17-OH was observed with increasing amounts of KZ. With 10, 50, and 100-fold excess KZ, the activity of 3β-HSD decreased by 59{\%} (P <0.001), 73{\%} (P <0.005), and 85{\%} (P <0.005), respectively. At equimolar concentrations with substrate (50 μM), KZ inhibited 17-OH by 70{\%} (P <0.01). No significant effect on ovarian AR activity was observed, except at the highest concentration of KZ tested. The authors conclude that low concentrations of KZ profoundly inhibit the activity of human ovarian 3β-HSD and 17-OH in vitro. These observations suggest that KZ might be useful in the medical management of women with hyperandrogenism, but further experimentation and clinical trials will be necessary.",
author = "M. DiMattina and N. Maronian and H. Ashby and Loriaux, {Donald (Lynn)} and Albertson, {B. D.}",
year = "1988",
language = "English (US)",
volume = "49",
pages = "62--65",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Ketoconazole inhibits multiple steroidogenic enzymes involved in androgen biosynthesis in the human ovary

AU - DiMattina, M.

AU - Maronian, N.

AU - Ashby, H.

AU - Loriaux, Donald (Lynn)

AU - Albertson, B. D.

PY - 1988

Y1 - 1988

N2 - Ketoconazole (KZ) has been shown to inhibit testicular and adrenal steroidogenesis and is useful in the medical management of gonadotropin-independent precocious puberty, prostatic cancer, and Cushing's syndrome. To determine whether KZ similarly affects ovarian steroidogenesis, the authors examined its effect on the activity of the human ovarian 3β-hydroxysteroid dehydrogenase/isomerase (3β-HSD), 17-hydroxylase (17-OH), and aromatase (AR) in vitro. A dose-dependent decrease in the activities of 3β-HSD and 17-OH was observed with increasing amounts of KZ. With 10, 50, and 100-fold excess KZ, the activity of 3β-HSD decreased by 59% (P <0.001), 73% (P <0.005), and 85% (P <0.005), respectively. At equimolar concentrations with substrate (50 μM), KZ inhibited 17-OH by 70% (P <0.01). No significant effect on ovarian AR activity was observed, except at the highest concentration of KZ tested. The authors conclude that low concentrations of KZ profoundly inhibit the activity of human ovarian 3β-HSD and 17-OH in vitro. These observations suggest that KZ might be useful in the medical management of women with hyperandrogenism, but further experimentation and clinical trials will be necessary.

AB - Ketoconazole (KZ) has been shown to inhibit testicular and adrenal steroidogenesis and is useful in the medical management of gonadotropin-independent precocious puberty, prostatic cancer, and Cushing's syndrome. To determine whether KZ similarly affects ovarian steroidogenesis, the authors examined its effect on the activity of the human ovarian 3β-hydroxysteroid dehydrogenase/isomerase (3β-HSD), 17-hydroxylase (17-OH), and aromatase (AR) in vitro. A dose-dependent decrease in the activities of 3β-HSD and 17-OH was observed with increasing amounts of KZ. With 10, 50, and 100-fold excess KZ, the activity of 3β-HSD decreased by 59% (P <0.001), 73% (P <0.005), and 85% (P <0.005), respectively. At equimolar concentrations with substrate (50 μM), KZ inhibited 17-OH by 70% (P <0.01). No significant effect on ovarian AR activity was observed, except at the highest concentration of KZ tested. The authors conclude that low concentrations of KZ profoundly inhibit the activity of human ovarian 3β-HSD and 17-OH in vitro. These observations suggest that KZ might be useful in the medical management of women with hyperandrogenism, but further experimentation and clinical trials will be necessary.

UR - http://www.scopus.com/inward/record.url?scp=0023864724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023864724&partnerID=8YFLogxK

M3 - Article

C2 - 3257193

AN - SCOPUS:0023864724

VL - 49

SP - 62

EP - 65

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 1

ER -